Tovanor Breezhaler is a medicine that is used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults. COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Tovanor Breezhaler is used for maintenance (regular) treatment. Tovanor Breezhaler contains the active substance glycopyrronium bromide.
Therapeutic Indication
### Therapeutic indication Tovanor Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Therapeutic Area (MeSH)
ATC Code
R03BB06
ATC Item
glycopyrronium bromide
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
EMA Name
Tovanor Breezhaler
Medicine Name
Tovanor Breezhaler
Aliases
N/ANo risk management plan link.
